These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 268729)

  • 1. [Serum methotrexate determination by microbiological assay in patients receiving high-dosage methotrexate (author's transl)].
    Krisch K; Kotz D; Mehta BM
    Wien Klin Wochenschr; 1977 Jul; 89(14):479-81. PubMed ID: 268729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of liver and renal functions on the changes in serum methotrexate (MTX) level in high-dose MTX therapy].
    Sato T; Nakanishi K; Takahashi M; Sato K; Miura T; Kuzuya T; Mizuno M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2375-9. PubMed ID: 2260874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
    Kotz R; Leber H; Ramach W; Arbes H; Wolf A
    Wien Klin Wochenschr; 1977 Jul; 89(14):474-9. PubMed ID: 70889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma.
    Bacci G; Loro L; Longhi A; Bertoni F; Bacchini P; Versari M; Picci P; Serra M
    Anticancer Drugs; 2006 Apr; 17(4):411-5. PubMed ID: 16549998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compatibility and toxicity of methotrexate in the treatment of bone tumors].
    Pongracz N; Kelaridis T; Ritschl P
    Arzneimittelforschung; 1987 Apr; 37(4):456-60. PubMed ID: 3496891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A device for rapid elevation of plasma methotrexate (MTX) concentration and its maintenance in high-dose MTX therapy].
    Miyauchi Y; Mii Y; Morishita T; Miura S; Honoki K; Aoki M; Kido A; Tamai S; Hino M; Nomura Y; Nakanishi E
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):595-9. PubMed ID: 8678518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate levels and outcome in osteosarcoma.
    Zelcer S; Kellick M; Wexler LH; Shi W; Sankaran M; Lo S; Healey J; Huvos AG; Meyers PA; Gorlick R
    Pediatr Blood Cancer; 2005 Jun; 44(7):638-42. PubMed ID: 15704189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [H-MTX-CF treatment and osteogenic sarcoma (author's transl)].
    Goto M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):235. PubMed ID: 6976923
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma.
    Delepine N; Delepine G; Cornille H; Brion F; Arnaud P; Desbois JC
    Anticancer Res; 1995; 15(2):489-94. PubMed ID: 7763028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Individualization of the dosage of high-dose methotrexate by assaying plasma concentration. Therapeutic value in osteogenic sarcoma].
    Delepine N; Desbois JC; Delepine G; Cornille H; Astier A; Alkallaf S
    Bull Cancer; 1989; 76(8):913-8. PubMed ID: 2620125
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].
    Leber H; Kotz R; Chiari K; Endler T; Gabl F; Krisch K; Salzer-Kuntschik M
    Wien Klin Wochenschr; 1981 Apr; 93(7):236-40. PubMed ID: 7020262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate clearance and clinical toxicity in osteosarcoma following high-dose methotrexate therapy.
    Iqbal MP; Khursheed M; Mahboobali N
    J Pak Med Assoc; 1989 Feb; 39(2):38-42. PubMed ID: 2499702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of methotrexate concentration in serum: comparison between capillary and venous blood].
    Bömelburg T; Ritter J; Schellong G
    Klin Padiatr; 1987; 199(3):230-2. PubMed ID: 3476803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature.
    Delepine N; Delepine G; Bacci G; Rosen G; Desbois JC
    Cancer; 1996 Nov; 78(10):2127-35. PubMed ID: 8918406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
    Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
    Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenic sarcoma: state of the art with high-dose methotrexate treatment.
    Jaffe N
    Clin Orthop Relat Res; 1976 Oct; (120):95-102. PubMed ID: 1086179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].
    Janka GE; Wiesner H; Bidlingmaier F; Haas RJ
    Klin Wochenschr; 1979 Apr; 57(8):411-6. PubMed ID: 313478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potential marker of the pharmacodynamic effect of high doses of methotrexate--homocysteine].
    Strizhevskaya AM; Senzhapova ER; Dzamraev AZ; Baykova VN
    Patol Fiziol Eksp Ter; 2014; (2):40-4. PubMed ID: 25318162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-pharmacological studies on the course of high-dose methotrexate therapy in childhood. A retrospective comparison of centers].
    Winograd B; Windorfer A; Wahlen W; Sitzman FC; Müller J; Wündisch G
    Dtsch Med Wochenschr; 1984 Jan; 109(4):127-32. PubMed ID: 6363035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.